By: Daniel Pierce and Marc Lobliner
Sometimes there is a cool addition to a commodity item, like adding Russian Tarragon to Creatine as Athletic Edge Nutrition did, that needs to be profiled. Then you have the commodity of all commodities, protein. Gaspari with its’ Myofusion Probiotic Series has added in a cool probiotic which is a great addition to any protein shake! Read on about the new GRAS status and why it is just a really cool and beneficial probiotic!
Ganeden Biotech announces that it’s received U.S. Food and Drug Administration (FDA) Generally Recognized As Safe (GRAS) status for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its spore-forming probiotic bacterium that supports the good bacteria found in the gut and displaces non-beneficial bacteria.
Based on the information provided regarding GRAS Notice No. 000399, as well as other information available to the FDA, the Agency has no questions or objections at this time regarding the expert panel conclusion that GanedenBC30 is GRAS under the intended conditions of use.
GanedenBC30 is the first Bacillus strain to receive GRAS status. Its composition differentiates itself from other probiotics with its ability to survive manufacturing processes, shelf life, stomach acids and intestinal bile. This allows GanedenBC30 to be incorporated into a variety of foods ranging from frozen yogurt and baked goods to hot cereals and confections. The strength of GanedenBC30 can be linked to its naturally occurring layer of organic material that protects the genetic core of the bacteria. Other probiotics, such as Lactobacillus and Bifidobacterium, are unable to form this protective layer, making them more vulnerable to manufacturing conditions.
Not All Probiotics Are Created Equal–Why this is in Myofusion Probiotic Series!
There is no doubt about it, probiotics are not another flash in the pan ingredient. Year over year, their presence has increased across all sales channels and research dollars have continued to accelerate into this burgeoning ingredient market. Experts can agree that as public awareness grows about the benefits of both gastrointestinal and immune health ingredients , these condition specific ingredients will continue to be on the rise, especially probiotics.
One common misconception about probiotics is that you need 5, 10, 20 billion colony forming units (CFU) for them to be effective. While that has proven to be true for some strains, Ganeden BC30 (Bacillus coagulans GBI-30, 6086) has been proven in a clinical setting in healthy humans at 500 million CFU. The facts are hard to overlook.
| Product Type | Claim | Probiotic Strain | Dose (CFU) |
| Myofusion Probiotic Series with | Supports immune health & digestion health | Ganeden BC30 (Bacillus coagulans GBI-30, 6086) | 500 million – 1 billion |
| Popular Yogurt | Support immune & digestion health | Bifidobacterium animalis | 10 billion |
| Popular Nutrition Bar | Supports immune & digestion health | Lactobacillus acidophilus | 6.1 billion |
| Popular Fruit Brink | Supports immune & digestion health | L. plantarum | 20 billion |
| Popular Cultured Milk | Supports immune and digestion health | L. casei | 8 billion |
| Popular Capsulated Product | Maintain healthy intestinal function | Saccharomyces boulardii | 5 billion |
| Popular Capsulated Product | Promotes good digestion and enhances immune system | Lactobacillus rhamnosus | 10 billion |
JUST THE FACTS
- Bacillus coagulans is surrounded by a natural protective shield. This protective layer helps Bacillus coagulans survive the heat and pressure of manufacturing and the acids in the stomach in order to arrive alive and intact in the intestines their intended target. Other traditional probiotic bacteria, such as bifidobacterium and lactobacillus, do not contain this protective outer shell.
- Bacillus coagulans, which are spore-forming bacteria that can be compared to a seed. When left alone, the seed is dormant – meaning to say it’s not alive, yet it’s not dead either. When this seed is put into the right temperature and moisture, it starts to germinate, or grow. Just as a seed waits for the proper conditions to start growing, so does the spore forming bacteria, Bacillus coagulans. However, for Bacillus coagulans, these conditions are met in the body’s intestinal tract. Here, the spore-forming bacteria meet the right temperature and moisture where they begin to grow and colonize – two critical factors for any probiotic bacteria.
- Most probiotic bacteria lack effective stability. Stability is the step in the manufacturing or fermentation of the organism that helps to ensure adequate shelf life. Some probiotic manufacturers use special additives to promote some measure of stability and others rely on refrigeration to accomplish this objective. But the harsh reality is that very few of the probiotic products on the market today have any real measure of long term stability.
- The ability of the probiotic to effectively colonize or take up temporary residence in the intestines is the end goal of use of probiotic products. Most probiotics are destroyed by gastric acid during ingestion. In addition, bile acid and some enzymes are inhibitory to these organisms and their respective numbers are depleted as a result. Fortunately, research has shown that Bacillus coagulans has an extremely high survivability percentage which has been demonstrated in various testing models. These same tests indicated a strong correlation with increased carbohydrate and protein absorption as well.
In the end, Bacillus coagulans is starting to surface as one of the truly effective leaders within the probiotic market. For this reason and all the great clinical data, safety assessments including self-affirmed GRAS status, the great survivability assessments, and room temperature shelf stability, it wasn’t a hard to choice to include Ganeden BC30 (Bacillus coagulans GBI-30, 6086) in Myofusion Probiotic Series. Your customers expect the best from you expect the best from Gaspari Nutrition. We delivered.
REFERENCES
Research in Microbiology. 2006 Oct;157(8):720-725.
Journal of Bacteriology. 2006 Mar;188(5):1979-86.
Journal of Dairy Science. 1997 Jun;80(6):1031-7.
FEMS Immunology & Medical Microbiology. 2001 Jul;31(1):35-9
Food & Chemical Toxicology. 2011 May;49(5):1174-82.
Anaerobe. 2011 Feb;17(1):36-42.
Beneficial Microbes. 2010 Mar;1(1):31-6.
Postgraduate Medicine. 2009 Mar;121(2):114-8.
Food & Chemical Toxicology. 2009 Jun;47(6):1231-8
Gastroenterology & Endoscopy News. 2010 June; 61(6):1-8